Results 201 to 210 of about 16,017 (247)
The Role of Rivals in Resource Picking from Factor Markets
Abstract While we know that rivals' activities in product markets are an important source of information, we know little about how firms set expectations and react to information emerging from competitors in strategic factor markets. Our theoretical framework examines this question and explains how rivals' actions in factor markets shape a firm's own ...
Jason T. Sigler +2 more
wiley +1 more source
Pharmacological Activity of Kaurenoic Acid Nanocarriers and Formulation Considerations for Therapeutic Cancer Applications. [PDF]
Ikechukwu P, Agu R.
europepmc +1 more source
Exploration Across Incompatible Technologies: How Firms Organize Flexibility for Innovation
ABSTRACT Firms often face multiple emerging technologies that evolve in parallel yet share limited architectural compatibility. In such settings, firms may concentrate innovation on one trajectory or pursue flexibility by maintaining engagement across multiple trajectories. We theorize that flexibility can improve innovation performance, but that these
Yong H. Kim +3 more
wiley +1 more source
Improvement of XZP8257 Dissolution Properties Through Amorphous and Mixed-Phase Precipitate Formation in Biorelevant Media. [PDF]
Zhang M +6 more
europepmc +1 more source
ABSTRACT Monoclonal antibodies (mAbs) represent a rapidly expanding pharmaceutical class in veterinary medicine, with several products now authorized for use in dogs and cats. Limited published articles and veterinarian exposure to the principles of drug development present challenges in interpreting published safety evaluations that inform product ...
Adam Werts +6 more
wiley +1 more source
BiotaPredictor: A machine learning framework for predicting drug depletion by the human gut microbiota. [PDF]
Naranjani B +7 more
europepmc +1 more source
Abstract Background and Objectives Parvovirus B19 (B19V) testing is often not required to release blood components. However, the European Pharmacopoeia requires that plasma pools for fractionation contain no more than 104 IU/mL of B19V DNA. In France, pool B19 nucleic acid testing (NAT) screening was performed by Établissement Français du Sang since ...
Virginie de la Taille +12 more
wiley +1 more source
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug Conjugates. [PDF]
Buitelaar PLM +4 more
europepmc +1 more source
Abstract figure legend New approach methodologies (NAMs) to test the pharmaco‐ and chemicokinetics of compound transfer across the human placental barrier in late pregnancy. Abstract This review addresses an important and timely topic at the intersection of placental biology with respect to barrier transfer kinetics, toxicology and mathematical ...
Paul Brownbill, Eleanor Doman
wiley +1 more source

